Business Wire

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

MOUNTAIN VIEW, Calif.-- (BUSINESS WIRE)--Vascular Dynamics, Inc., a private medical device company developing novel solutions for the treatment of hypertension, today announced receipt of CE Mark ...
Yahoo Finance

Vascular Dynamics, Inc. Initiates "First in Human" Clinical Study of Its MobiusHDTM Device for the Treatment of Drug Resistant Hypertension

MOUNTAIN VIEW, CA--(Marketwired - Sep 23, 2013) - Vascular Dynamics, Inc. (VDI) announced today the first patient has been treated with the MobiusHD ™ device; a catheter-delivered implant designed for ...
Business Insider

Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six MonthsCompany Has Initiated ...

MOUNTAIN VIEW, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., a privately held medical device company developing novel solutions for the treatment of hypertension, will present ...
Yahoo Finance

Vascular Dynamics' Announces Expedited Access Pathway Designation by FDA for MobiusHD® to Accelerate US Access for Treatment of Resistant Hypertension

MOUNTAIN VIEW, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today ...
PR Newswire

Vascular Dynamics, a Part of the Rainbow Medical Investment Cluster, Received FDA Approval to Begin Conclusive and Pivotal Trial Experimentation for Their Flagship Product ...

The experiment will examine the effectiveness of the MobiusHD implant in the reduction of blood pressure among chronic patients for whom at least three different medications proved ineffective. The ...
Business Insider

Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension

MOUNTAIN VIEW, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today ...
Business Wire

Vascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD Device

IRVINE, Calif.--(BUSINESS WIRE)--Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering ...
BioWorld

Vascular Dynamics receives approval for pivotal trial to treat resistant hypertension

Vascular Dynamics Inc. (VDI), a private company, said the FDA has approved an IDE application to initiate a pivotal trial for the Mobiushd system in the treatment of resistant hypertension. The ...
TCTMD

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

MOUNTAIN VIEW, Calif., Vascular Dynamics, Inc., a private medical device company developing novel solutions for the treatment of hypertension, today announced receipt of CE Mark approval for its ...
Finanznachrichten

Vascular Dynamics, Inc.: Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six Months

Company Has Initiated Pivotal Trial for the MobiusHD in the US and EU MOUNTAIN VIEW, Calif., 2017-10-30 14:45 CET (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., a privately held medical device company ...